Medical Properties Trust (NYSE:MPW) Announces Earnings Results

Medical Properties Trust (NYSE:MPW) announced its quarterly earnings results on Thursday. The real estate investment trust reported $0.31 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.31, Briefing.com reports. The business had revenue of $192.55 million during the quarter, compared to analyst estimates of $186.11 million. Medical Properties Trust had a net margin of 131.84% and a return on equity of 7.98%. Medical Properties Trust’s quarterly revenue was down 4.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.36 EPS. Medical Properties Trust updated its FY 2019 guidance to $1.56-1.58 EPS.

Shares of NYSE MPW traded down $0.12 during trading on Friday, hitting $17.73. The stock had a trading volume of 32,217 shares, compared to its average volume of 6,489,973. Medical Properties Trust has a 12 month low of $13.98 and a 12 month high of $18.92. The company has a quick ratio of 9.37, a current ratio of 9.37 and a debt-to-equity ratio of 0.82. The firm has a market capitalization of $6.98 billion, a P/E ratio of 12.96, a PEG ratio of 3.31 and a beta of 0.59. The company’s fifty day moving average price is $17.97.

The company also recently announced a quarterly dividend, which was paid on Thursday, July 11th. Stockholders of record on Thursday, June 13th were paid a $0.25 dividend. The ex-dividend date of this dividend was Wednesday, June 12th. This represents a $1.00 annualized dividend and a dividend yield of 5.64%. Medical Properties Trust’s payout ratio is 72.99%.

In other news, Director Michael G. Stewart sold 6,830 shares of the company’s stock in a transaction on Friday, June 7th. The shares were sold at an average price of $18.47, for a total value of $126,150.10. Following the completion of the sale, the director now owns 224,615 shares in the company, valued at approximately $4,148,639.05. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.18% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of MPW. Oakbrook Investments LLC grew its position in Medical Properties Trust by 3.0% during the first quarter. Oakbrook Investments LLC now owns 20,400 shares of the real estate investment trust’s stock valued at $378,000 after buying an additional 600 shares during the period. 6 Meridian grew its position in Medical Properties Trust by 2.2% during the second quarter. 6 Meridian now owns 28,528 shares of the real estate investment trust’s stock valued at $498,000 after buying an additional 606 shares during the period. Oliver Luxxe Assets LLC grew its position in Medical Properties Trust by 4.2% during the first quarter. Oliver Luxxe Assets LLC now owns 16,456 shares of the real estate investment trust’s stock valued at $305,000 after buying an additional 656 shares during the period. World Asset Management Inc grew its position in Medical Properties Trust by 4.0% during the second quarter. World Asset Management Inc now owns 18,492 shares of the real estate investment trust’s stock valued at $323,000 after buying an additional 718 shares during the period. Finally, Claraphi Advisory Network LLC grew its position in Medical Properties Trust by 0.7% during the second quarter. Claraphi Advisory Network LLC now owns 100,151 shares of the real estate investment trust’s stock valued at $1,747,000 after buying an additional 732 shares during the period. Hedge funds and other institutional investors own 80.52% of the company’s stock.

A number of analysts have commented on MPW shares. SunTrust Banks upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating and boosted their price target for the company from $19.00 to $20.00 in a research note on Tuesday, July 2nd. ValuEngine lowered shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a research note on Thursday. Deutsche Bank upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating in a research note on Monday. Zacks Investment Research lowered shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a research note on Wednesday, July 17th. Finally, Stifel Nicolaus upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating and upped their target price for the stock from $18.00 to $19.00 in a research note on Tuesday, July 23rd. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $18.69.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Recommended Story: Moving Average Convergence Divergence (MACD)

Earnings History for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.